Skip to content

Opening book details…

Can I read Epigenetics and Disease: Pharmaceutical Opportunities (Progress in Drug Research Book 67) on EtoBox?

Epigenetics and Disease: Pharmaceutical Opportunities (Progress in Drug Research Book 67) by Phillippa C. Taberlay, Peter A. Jones (auth.), Susan M. Gasser, En Li (eds.) is a medicine available to read on EtoBox.

What is Epigenetics and Disease: Pharmaceutical Opportunities (Progress in Drug Research Book 67) about?

Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders. Recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological inte

Who reads Epigenetics and Disease: Pharmaceutical Opportunities (Progress in Drug Research Book 67)?

It is typically read by working professionals who need an authoritative practice reference.

Common subject areas: medicine, law, business, engineering.

Author
Phillippa C. Taberlay, Peter A. Jones (auth.), Susan M. Gasser, En Li (eds.)
Publisher
Springer Basel : Imprint: Springer
Published
2011
Language
EN
ISBN
9783764389895
Category
medicine
Subjects
Medical, Genetics, Clinical Medicine
Updated
2026-03-25

Other editions & translations

More by Phillippa C. Taberlay, Peter A. Jones (auth.), Susan M. Gasser, En Li (eds.)

Browse all works by Phillippa C. Taberlay, Peter A. Jones (auth.), Susan M. Gasser, En Li (eds.)

Similar books